摘要
目的探讨血浆D-二聚体早期诊断急性肠系膜缺血性疾病的方法和临床价值。方法选取30例急性肠系膜缺血性疾病患者作为观察组,选取同期30例健康体检者作为对照组,全部研究对象均行血浆D-二聚体测定,观察其检测结果。结果观察组患者入院第1天、第7天、第10天血浆D-二聚体含量分别为(6.87±2.10)、(3.33±1.20)、(2.33±1.20)mg/L,对照组分别为(0.36±0.06)、(0.36±0.06)、(0.36±0.06)mg/L;观察组患者不同时间血浆D-二聚体含量均显著高于对照组,差异有统计学意义(P<0.05)。血浆D-二聚体进行疾病诊断的敏感度为76.67%(23/30),特异度为80.00%(24/30)。结论对急性肠系膜缺血性疾病患者实施血浆D-二聚体早期诊断可早期筛查疾病,降低患者的死亡率,值得临床进行推广。
Objective To explore the methods and clinical value of plasma D-dimer in early diagnosis of acute mesenteric ischemia. Methods There were 30 acute mesenterie ischemia patients as observation group, and concurrent 30 physical examination people as control group. Both groups received detection of plasma D-dimer, and detection results were observed. Results The observation group had plasma D-dimer content at 1, 7 and 10 days of admission respectively as （6.87 ± 2.10）, （3.33 ±1.20） and （2.33 ± 1.20） mg/L, which were respectively as （0.36 ±0.06）, （0.36 ± 0.06） and （0.36 ± 0.06） mg/L in the control group. The observation group had significantly higher plasma D-dimer content at different time points than the control group, and the difference had statistical significance （P〈0.05）. Diagnostic sensitivity of plasma D-dimcr was 76.67% （23/30）, and the specificity was 80.00% （24/30）. Conclusion For acute mesenteric ischemia patients, implement of plasma D-dimer for early diagnosis can early screen disease and reduce mortality of patients. So it is worthy of clinical promotion.
出处
《中国实用医药》
2017年第12期32-33,共2页
China Practical Medicine
